Catalyst Pharmaceuticals (CPRX) Stake Maintained by Broadfin Capital Llc; Oak Associates LTD Has Lowered Holding in Western Union (WU) by $333,070

April 19, 2018 - By Henry Gaston

Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Logo

Kevin Kotler increased its stake in Catalyst Pharmaceuticals Inc (CPRX) by 2.97% based on its latest 2017Q4 regulatory filing with the SEC. Broadfin Capital Llc bought 204,800 shares as the company’s stock declined 36.55% with the market. The hedge fund run by Kevin Kotler held 7.10 million shares of the health care company at the end of 2017Q4, valued at $27.75M, up from 6.89M at the end of the previous reported quarter. Broadfin Capital Llc who had been investing in Catalyst Pharmaceuticals Inc for a number of months, seems to be bullish on the $261.52M market cap company. The stock increased 0.39% or $0.01 during the last trading session, reaching $2.55. About 492,631 shares traded. Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) has risen 24.38% since April 19, 2017 and is uptrending. It has outperformed by 12.83% the S&P500.

Oak Associates Ltd decreased its stake in Western Union (WU) by 7.9% based on its latest 2017Q4 regulatory filing with the SEC. Oak Associates Ltd sold 17,530 shares as the company’s stock declined 1.00% with the market. The institutional investor held 204,340 shares of the business services company at the end of 2017Q4, valued at $3.89 million, down from 221,870 at the end of the previous reported quarter. Oak Associates Ltd who had been investing in Western Union for a number of months, seems to be less bullish one the $8.92B market cap company. The stock decreased 0.21% or $0.04 during the last trading session, reaching $19.37. About 3.60M shares traded. The Western Union Company (NYSE:WU) has declined 5.69% since April 19, 2017 and is downtrending. It has underperformed by 17.24% the S&P500.

Since January 8, 2018, it had 0 buys, and 2 insider sales for $1.44 million activity. $1.09 million worth of The Western Union Company (NYSE:WU) was sold by Farah Jean Claude.

Oak Associates Ltd, which manages about $1.01 billion and $1.41 billion US Long portfolio, upped its stake in Marvell Technology Grp (NASDAQ:MRVL) by 51,230 shares to 224,630 shares, valued at $4.82M in 2017Q4, according to the filing. It also increased its holding in Netapp Inc. (NASDAQ:NTAP) by 25,785 shares in the quarter, for a total of 297,830 shares, and has risen its stake in Kla (NASDAQ:KLAC).

Among 18 analysts covering The Western Union Company (NYSE:WU), 2 have Buy rating, 7 Sell and 9 Hold. Therefore 11% are positive. The Western Union Company had 37 analyst reports since July 31, 2015 according to SRatingsIntel. The rating was downgraded by Compass Point to “Sell” on Friday, January 20. On Friday, October 20 the stock rating was maintained by RBC Capital Markets with “Hold”. Susquehanna downgraded The Western Union Company (NYSE:WU) on Monday, September 19 to “Negative” rating. The stock has “Sell” rating by Mizuho on Friday, October 13. The firm has “Buy” rating by Zacks given on Tuesday, September 1. The rating was maintained by RBC Capital Markets with “Hold” on Monday, July 17. The stock has “Hold” rating by Stifel Nicolaus on Friday, August 4. The rating was maintained by Stifel Nicolaus on Tuesday, January 16 with “Hold”. The rating was maintained by Morgan Stanley with “Underweight” on Friday, November 3. The stock has “Sell” rating by Citigroup on Thursday, August 4.

Analysts await The Western Union Company (NYSE:WU) to report earnings on May, 1 after the close. They expect $0.42 EPS, up 20.00% or $0.07 from last year’s $0.35 per share. WU’s profit will be $193.46 million for 11.53 P/E if the $0.42 EPS becomes a reality. After $0.41 actual EPS reported by The Western Union Company for the previous quarter, Wall Street now forecasts 2.44% EPS growth.

Investors sentiment increased to 1.07 in 2017 Q4. Its up 0.19, from 0.88 in 2017Q3. It improved, as 30 investors sold WU shares while 166 reduced holdings. 62 funds opened positions while 147 raised stakes. 463.88 million shares or 1.01% more from 459.24 million shares in 2017Q3 were reported. Lee Danner And Bass Inc reported 25,575 shares. Mitsubishi Ufj Trust Banking stated it has 974,918 shares or 0.03% of all its holdings. Pggm Invests owns 908,100 shares for 0.1% of their portfolio. Daiwa Grp Inc invested in 0% or 15,227 shares. 71,595 are owned by Laffer Invests. State Of Tennessee Treasury Department stated it has 0.01% of its portfolio in The Western Union Company (NYSE:WU). Sei Invs Company has 0.04% invested in The Western Union Company (NYSE:WU) for 548,892 shares. Cubist Systematic Strategies Ltd holds 178,539 shares or 0.18% of its portfolio. Price T Rowe Associates Md accumulated 782,142 shares. 13,228 are owned by Lincoln Corporation. 484,600 are owned by Her Majesty The Queen In Right Of The Province Of Alberta As Represented By Alberta Invest Mngmt. Pub Employees Retirement Association Of Colorado holds 0.01% in The Western Union Company (NYSE:WU) or 84,352 shares. Fmr Limited Com has 41.57M shares for 0.09% of their portfolio. State Of Alaska Department Of Revenue invested 0.05% in The Western Union Company (NYSE:WU). New Hampshire-based Ledyard Retail Bank has invested 0.08% in The Western Union Company (NYSE:WU).

Among 5 analysts covering Catalyst Pharmaceuticals (NASDAQ:CPRX), 5 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Catalyst Pharmaceuticals had 14 analyst reports since April 26, 2016 according to SRatingsIntel. SunTrust maintained Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) rating on Tuesday, October 31. SunTrust has “Buy” rating and $5.0 target. The rating was maintained by Roth Capital on Thursday, August 10 with “Buy”. H.C. Wainwright maintained the shares of CPRX in report on Thursday, March 15 with “Buy” rating. The stock has “Buy” rating by Piper Jaffray on Friday, December 1. The firm earned “Overweight” rating on Wednesday, October 5 by Piper Jaffray. The firm earned “Buy” rating on Friday, August 11 by H.C. Wainwright. H.C. Wainwright maintained the shares of CPRX in report on Friday, November 10 with “Buy” rating. The stock has “Neutral” rating by Piper Jaffray on Tuesday, April 26. The firm has “Buy” rating given on Monday, August 7 by Piper Jaffray. SunTrust maintained Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) on Monday, November 27 with “Buy” rating.

Investors sentiment decreased to 1.97 in 2017 Q4. Its down 0.03, from 2 in 2017Q3. It dived, as 11 investors sold CPRX shares while 19 reduced holdings. 34 funds opened positions while 25 raised stakes. 55.25 million shares or 59.14% more from 34.72 million shares in 2017Q3 were reported. 341,956 are owned by Ameriprise Fincl. Cwm Lc accumulated 0% or 500 shares. 108,649 are held by Bogle Inv LP De. California State Teachers Retirement Sys stated it has 0% in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX). Moreover, Fmr Limited has 0% invested in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX). Aqr Cap Mgmt Limited Liability Co holds 0% of its portfolio in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) for 336,578 shares. Grp One Trading Limited Partnership has 0% invested in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX). Macquarie Grp Inc Limited reported 2,100 shares. New York State Common Retirement Fund reported 50,794 shares. Pennsylvania-based Vanguard Group Inc has invested 0% in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX). Great Point Prtn Ltd Liability Company reported 3.82M shares. 54,000 were reported by State Of Wisconsin Inv Board. Hbk Sorce Advisory Ltd Liability reported 0.01% of its portfolio in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX). Bnp Paribas Arbitrage invested in 0% or 14,857 shares. Mangrove Prns reported 924,648 shares.

Since April 3, 2018, it had 1 insider buy, and 0 insider sales for $45,800 activity.

Broadfin Capital Llc, which manages about $1.26 billion and $611.75 million US Long portfolio, decreased its stake in Ignyta Inc (NASDAQ:RXDX) by 344,283 shares to 1.15 million shares, valued at $30.71 million in 2017Q4, according to the filing. It also reduced its holding in La Jolla Pharmaceutical Co (NASDAQ:LJPC) by 28,272 shares in the quarter, leaving it with 1.03M shares, and cut its stake in Horizon Pharma Plc (Call) (NASDAQ:HZNP).

Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Institutional Positions Chart

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>